| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,245 |
10,127 |
$4.87M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,090 |
15,739 |
$4.71M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,000 |
15,902 |
$4.06M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,855 |
2,692 |
$2.08M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,082 |
1,934 |
$982K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,209 |
5,851 |
$902K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,040 |
2,854 |
$436K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
202 |
185 |
$220K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
624 |
585 |
$153K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
250 |
242 |
$84K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
856 |
649 |
$35K |
| 70496 |
|
26 |
26 |
$19K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,959 |
2,618 |
$13K |
| 93971 |
|
197 |
186 |
$10K |
| 80320 |
|
2,856 |
2,615 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,704 |
8,859 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,074 |
2,792 |
$5K |
| J3490 |
Unclassified drugs |
9,427 |
6,152 |
$5K |
| 80053 |
Comprehensive metabolic panel |
19,761 |
17,231 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,095 |
10,050 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
2,682 |
2,545 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,686 |
8,269 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,150 |
3,716 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
8,002 |
7,306 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,183 |
3,041 |
$2K |
| G0378 |
Hospital observation service, per hour |
197 |
108 |
$1K |
| 87631 |
|
593 |
575 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,620 |
18,917 |
$1K |
| 83690 |
|
8,326 |
7,507 |
$777.86 |
| 84484 |
|
7,531 |
5,025 |
$583.25 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,634 |
4,140 |
$574.74 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
627 |
592 |
$561.94 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,436 |
6,814 |
$440.11 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,142 |
1,684 |
$395.36 |
| 96376 |
|
2,470 |
1,941 |
$383.69 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,152 |
1,079 |
$381.37 |
| 73130 |
|
758 |
725 |
$370.84 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,259 |
1,214 |
$333.13 |
| 81025 |
|
3,836 |
3,633 |
$330.73 |
| 12001 |
|
58 |
55 |
$292.70 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
596 |
557 |
$285.07 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,194 |
4,844 |
$275.13 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
401 |
387 |
$275.00 |
| 81001 |
|
7,771 |
7,160 |
$272.38 |
| 84703 |
|
711 |
684 |
$267.99 |
| 73562 |
|
629 |
573 |
$266.86 |
| 73630 |
|
830 |
784 |
$248.32 |
| 87077 |
|
1,961 |
1,616 |
$241.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,481 |
3,051 |
$229.38 |
| 72100 |
|
25 |
24 |
$221.31 |
| 87040 |
|
3,287 |
1,585 |
$212.99 |
| A9270 |
Non-covered item or service |
8,093 |
2,742 |
$162.84 |
| 73030 |
|
366 |
337 |
$159.89 |
| 83880 |
|
1,098 |
1,004 |
$147.48 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,740 |
4,418 |
$133.92 |
| 83735 |
|
4,099 |
3,529 |
$125.37 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
312 |
306 |
$110.81 |
| 83605 |
|
3,833 |
2,991 |
$106.70 |
| 90715 |
|
459 |
452 |
$95.28 |
| 73610 |
|
531 |
500 |
$81.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,218 |
4,566 |
$76.58 |
| 82947 |
|
3,052 |
2,075 |
$65.56 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
11,269 |
6,809 |
$63.12 |
| 87088 |
|
3,876 |
3,470 |
$62.57 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,066 |
6,274 |
$53.32 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
812 |
787 |
$51.31 |
| 84702 |
|
1,216 |
1,142 |
$49.95 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,280 |
616 |
$47.88 |
| 73110 |
|
189 |
169 |
$45.69 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
1,897 |
1,720 |
$44.97 |
| 81003 |
|
3,254 |
3,071 |
$44.22 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,822 |
3,227 |
$43.02 |
| 85610 |
|
2,715 |
2,437 |
$34.73 |
| 82803 |
|
96 |
83 |
$33.98 |
| 82550 |
|
974 |
858 |
$32.97 |
| 87186 |
|
1,501 |
1,313 |
$31.15 |
| 87081 |
|
295 |
283 |
$29.23 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
920 |
778 |
$27.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,278 |
1,199 |
$25.96 |
| J1790 |
Injection, droperidol, up to 5 mg |
577 |
522 |
$25.32 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,341 |
2,086 |
$15.95 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
486 |
433 |
$12.61 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,246 |
1,983 |
$12.49 |
| 86850 |
|
71 |
68 |
$11.85 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
610 |
529 |
$10.55 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
531 |
511 |
$8.92 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
761 |
691 |
$7.58 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
61 |
51 |
$7.50 |
| 85379 |
|
383 |
358 |
$7.33 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
890 |
835 |
$6.93 |
| 85730 |
|
698 |
639 |
$6.67 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
460 |
377 |
$5.84 |
| J2060 |
Injection, lorazepam, 2 mg |
1,103 |
953 |
$5.82 |
| 86901 |
|
333 |
308 |
$5.29 |
| 86900 |
|
173 |
159 |
$5.22 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
32 |
25 |
$4.90 |
| 86140 |
|
478 |
424 |
$4.60 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
591 |
549 |
$1.80 |
| 93976 |
|
309 |
293 |
$0.00 |
| 96367 |
|
377 |
334 |
$0.00 |
| 84100 |
|
149 |
127 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
52 |
41 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
69 |
63 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
93 |
90 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
27 |
26 |
$0.00 |
| 74018 |
|
64 |
63 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
156 |
138 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
41 |
41 |
$0.00 |
| 85055 |
|
32 |
26 |
$0.00 |
| 73080 |
|
13 |
12 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
12 |
12 |
$0.00 |
| 87210 |
|
26 |
25 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
13 |
12 |
$0.00 |
| 82010 |
|
16 |
14 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
140 |
136 |
$0.00 |
| 51702 |
|
15 |
13 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
37 |
28 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
108 |
92 |
$0.00 |
| 87807 |
|
28 |
28 |
$0.00 |
| 85027 |
|
470 |
395 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
64 |
59 |
$0.00 |
| 80329 |
|
356 |
326 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
496 |
337 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
158 |
117 |
$0.00 |
| 73502 |
|
16 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
59 |
40 |
$0.00 |
| 70498 |
|
26 |
26 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
93 |
90 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
16 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
45 |
37 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
90 |
88 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
17 |
17 |
$0.00 |